Research Nester has recently announced its latest research on “Mobile Medical Apps Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global mobile medical apps market in terms of market segmentation by service, by therapeutic applications, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
The market for mobile medical apps is anticipated to record a CAGR of about 35% during the forecast period, i.e., 2019-2027. The market is segmented by service, by therapeutic applications, by end user and by region. On the basis of end user, the market is further bifurcated into healthcare providers and patients, out of which, the patients segment is estimated to witness the highest growth during the upcoming years. This can be attributed to the rising trend of self-management of various health disorders and growing usage of mobile applications for healthcare services.
The market in Asia Pacific region is anticipated to grow at the highest rate during the forecast period as a result of increasing developments in the healthcare industry and rising government initiatives in the region. The increasing awareness for mobile health is another factor estimated to boost the market growth. The market in North America is anticipated to lead the market share in mobile medical apps market on account of rising technological advancements in healthcare in the region.
Rising Prevalence Of Chronic Health Disorders To Propel The Market Growth
According to the Centers for Disease Control and Prevention (CDC), about 1 in every 3 adults are anticipated to have diabetes by the year 2050. Increasing prevalence of a number of chronic disorders is a major factor estimated to result in the market growth. The requirement for mobile applications which make it easier to diagnose, monitor and cure the disorders is an addition factor anticipated to support the growth of mobile medical apps market.
However, strict policies regarding the FDA approval of some medical mobile applications that provide treatment recommendations for serious medical conditions such as those pertaining to cardiovascular and neurological risks are estimated to become the major restricting factor for the market growth.
This report also provides the existing competitive scenario of some of the key players of the global mobile medical apps market which includes company profiling of Welldoc, AliveCor, F. Hoffmann-La Roche(ROG), Fitbit Inc. (FIT), Medtronic (MDT), Boston Scientific Corporation (BSX), Johnson & Johnson (JNJ), Abbott Laboratories (ABT), Azumio and Cohero Health Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global mobile medical apps market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.